Decreased serum carbohydrate antigen 19–9 levels after neoadjuvant therapy predict a better prognosis for patients with pancreatic adenocarcinoma: a multicenter ... View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2019-03-21

AUTHORS

Shuichi Aoki, Fuyuhiko Motoi, Yoshiaki Murakami, Masayuki Sho, Sohei Satoi, Goro Honda, Kenichiro Uemura, Ken-ichi Okada, Ippei Matsumoto, Minako Nagai, Hiroaki Yanagimoto, Masanao Kurata, Takumi Fukumoto, Masamichi Mizuma, Hiroki Yamaue, Michiaki Unno,

ABSTRACT

BACKGROUND: Carbohydrate antigen (CA) 19-9 levels after resection are considered to predict prognosis; however, the significance of decreased CA19-9 levels after neoadjuvant therapy has not been clarified. This study aimed to define the prognostic significance of decreased CA19-9 levels after neoadjuvant therapy in patients with pancreatic adenocarcinoma. METHODS: Between 2001 and 2012, 240 consecutive patients received neoadjuvant therapy and subsequent resection at seven high-volume institutions in Japan. These patients were divided into three groups: Normal group (no elevation [≤37 U/ml] before and after neoadjuvant therapy), Responder group (elevated levels [> 37 U/ml] before neoadjuvant therapy but decreased levels [≤37 U/ml] afterwards), and Non-responder group (elevated levels [> 37 U/ml] after neoadjuvant therapy). Analyses of overall survival and recurrence patterns were performed. Uni- and multivariate analyses were performed to clarify the clinicopathological factors influencing overall survival. The initial metastasis sites were also evaluated in these groups. RESULTS: The Responder group received a better prognosis than the Non-responder group (3-year overall survival: 50.6 and 41.6%, respectively, P = 0.026), but the prognosis was comparable to the Normal group (3-year overall survival: 54.2%, P = 0.934). According to the analysis of the receiver operating characteristic curve, the CA19-9 cut-off level defined as no elevation after neoadjuvant therapy was ≤103 U/ml. The multivariate analysis revealed that a CA19-9 level ≤ 103 U/ml, (P = 0.010, hazard ratio: 1.711; 95% confidence interval: 1.133-2.639), tumor size ≤27 mm (P = 0.040, 1.517; (1.018-2.278)), a lack of lymph node metastasis (P = 0.002, 1.905; (1.276-2.875)), and R0 status (P = 0.045, 1.659; 1.012-2.627) were significant predictors of overall survival. Moreover, the Responder group showed a lower risk of hepatic recurrence (18%) compared to the Non-responder group (31%), though no significant difference in loco-regional, peritoneal or other distant recurrence were observed between groups (P = 0.058, P = 0.700 and P = 0.350, respectively). CONCLUSIONS: Decreased CA19-9 levels after neoadjuvant therapy predicts a better prognosis, with low incidence of hepatic recurrence after surgery. More... »

PAGES

252

References to SciGraph publications

  • 2011-08-24. Prognostic Impact of Postoperative Serum CA 19-9 Levels in Patients with Resectable Pancreatic Cancer in ANNALS OF SURGICAL ONCOLOGY
  • 2011-08-31. A Randomized Trial Comparing Postoperative Adjuvant Chemotherapy with Cisplatin and 5-Fluorouracil Versus Preoperative Chemotherapy for Localized Advanced Squamous Cell Carcinoma of the Thoracic Esophagus (JCOG9907) in ANNALS OF SURGICAL ONCOLOGY
  • 2011-04-01. Adjuvant surgical therapy for patients with initially-unresectable pancreatic cancer with long-term favorable responses to chemotherapy in JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES
  • 2009-08-18. A randomised phase III trial comparing gemcitabine with surgery-only in patients with resected pancreatic cancer: Japanese Study Group of Adjuvant Therapy for Pancreatic Cancer in BRITISH JOURNAL OF CANCER
  • 2010-03-25. Prognostic Impact of Perioperative Serum CA 19-9 Levels in Patients with Resectable Pancreatic Cancer in ANNALS OF SURGICAL ONCOLOGY
  • 2010-09-15. Retrospective Evaluation of the Influence of Postoperative Tumor Marker Status on Survival and Patterns of Recurrence After Surgery for Pancreatic Cancer Based on RECIST Guidelines in ANNALS OF SURGICAL ONCOLOGY
  • 2007-04-24. A Randomized Phase 2 Trial of Neoadjuvant Chemotherapy in Resectable Pancreatic Cancer: Gemcitabine Alone Versus Gemcitabine Combined with Cisplatin in ANNALS OF SURGICAL ONCOLOGY
  • 2012-03-13. Serum CA19-9 is a Significant Predictor among Preoperative Parameters for Early Recurrence after Resection of Pancreatic Adenocarcinoma in JOURNAL OF GASTROINTESTINAL SURGERY
  • 2013-05-10. Role of adjuvant surgery for patients with initially unresectable pancreatic cancer with a long-term favorable response to non-surgical anti-cancer treatments: results of a project study for pancreatic surgery by the Japanese Society of Hepato-Biliary-Pancreatic Surgery in JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES
  • 1997-02. Recurrence after resection for ductal adenocarcinoma of the pancreas in WORLD JOURNAL OF SURGERY
  • 2009-05-06. The Lymph Node Ratio is the Strongest Prognostic Factor after Resection of Pancreatic Cancer in JOURNAL OF GASTROINTESTINAL SURGERY
  • Journal

    TITLE

    BMC Cancer

    ISSUE

    1

    VOLUME

    19

    Identifiers

    URI

    http://scigraph.springernature.com/pub.10.1186/s12885-019-5460-4

    DOI

    http://dx.doi.org/10.1186/s12885-019-5460-4

    DIMENSIONS

    https://app.dimensions.ai/details/publication/pub.1112926598

    PUBMED

    https://www.ncbi.nlm.nih.gov/pubmed/30898101


    Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
    Incoming Citations Browse incoming citations for this publication using opencitations.net

    JSON-LD is the canonical representation for SciGraph data.

    TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

    [
      {
        "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
        "about": [
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Medical and Health Sciences", 
            "type": "DefinedTerm"
          }, 
          {
            "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112", 
            "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
            "name": "Oncology and Carcinogenesis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Adult", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Aged, 80 and over", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Antineoplastic Combined Chemotherapy Protocols", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "CA-19-9 Antigen", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Carcinoma, Pancreatic Ductal", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Case-Control Studies", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Female", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Humans", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Incidence", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Liver Neoplasms", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Male", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Middle Aged", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Neoadjuvant Therapy", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Neoplasm Recurrence, Local", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Pancreatectomy", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Pancreatic Neoplasms", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Prognosis", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Response Evaluation Criteria in Solid Tumors", 
            "type": "DefinedTerm"
          }, 
          {
            "inDefinedTermSet": "https://www.nlm.nih.gov/mesh/", 
            "name": "Survival Analysis", 
            "type": "DefinedTerm"
          }
        ], 
        "author": [
          {
            "affiliation": {
              "alternateName": "Department of Surgery, Tohoku University Graduate School of Medicine, 1-1, Seiryo-machi, Aobaku, Sendai, Miyagi 980-8574 Japan", 
              "id": "http://www.grid.ac/institutes/grid.69566.3a", 
              "name": [
                "Department of Surgery, Tohoku University Graduate School of Medicine, 1-1, Seiryo-machi, Aobaku, Sendai, Miyagi 980-8574 Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Aoki", 
            "givenName": "Shuichi", 
            "id": "sg:person.0623100010.00", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0623100010.00"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Surgery, Tohoku University Graduate School of Medicine, 1-1, Seiryo-machi, Aobaku, Sendai, Miyagi 980-8574 Japan", 
              "id": "http://www.grid.ac/institutes/grid.69566.3a", 
              "name": [
                "Department of Surgery, Tohoku University Graduate School of Medicine, 1-1, Seiryo-machi, Aobaku, Sendai, Miyagi 980-8574 Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Motoi", 
            "givenName": "Fuyuhiko", 
            "id": "sg:person.01260427553.25", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01260427553.25"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Surgery, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, 734-8553 Japan", 
              "id": "http://www.grid.ac/institutes/grid.257022.0", 
              "name": [
                "Department of Surgery, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, 734-8553 Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Murakami", 
            "givenName": "Yoshiaki", 
            "id": "sg:person.0740320344.58", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0740320344.58"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Surgery, Nara Medical University, Nara, 634-8521 Japan", 
              "id": "http://www.grid.ac/institutes/grid.410814.8", 
              "name": [
                "Department of Surgery, Nara Medical University, Nara, 634-8521 Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Sho", 
            "givenName": "Masayuki", 
            "id": "sg:person.0705470262.13", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0705470262.13"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Surgery, Kansai Medical University, Osaka, 573-1010 Japan", 
              "id": "http://www.grid.ac/institutes/grid.410783.9", 
              "name": [
                "Department of Surgery, Kansai Medical University, Osaka, 573-1010 Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Satoi", 
            "givenName": "Sohei", 
            "id": "sg:person.01122437244.79", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01122437244.79"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Surgery, Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital, Tokyo, 113-8677 Japan", 
              "id": "http://www.grid.ac/institutes/grid.415479.a", 
              "name": [
                "Department of Surgery, Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital, Tokyo, 113-8677 Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Honda", 
            "givenName": "Goro", 
            "id": "sg:person.01342345220.29", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01342345220.29"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Surgery, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, 734-8553 Japan", 
              "id": "http://www.grid.ac/institutes/grid.257022.0", 
              "name": [
                "Department of Surgery, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, 734-8553 Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Uemura", 
            "givenName": "Kenichiro", 
            "id": "sg:person.01151604541.22", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01151604541.22"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Second Department of Surgery, Wakayama Medical University, Wakayama, 641-8510 Japan", 
              "id": "http://www.grid.ac/institutes/grid.412857.d", 
              "name": [
                "Second Department of Surgery, Wakayama Medical University, Wakayama, 641-8510 Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Okada", 
            "givenName": "Ken-ichi", 
            "id": "sg:person.01270724636.90", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01270724636.90"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Surgery, Kindai University Faculty of Medicine, Osaka, 577-8502 Japan", 
              "id": "http://www.grid.ac/institutes/grid.258622.9", 
              "name": [
                "Department of Surgery, Kindai University Faculty of Medicine, Osaka, 577-8502 Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Matsumoto", 
            "givenName": "Ippei", 
            "id": "sg:person.01142257124.18", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01142257124.18"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Surgery, Nara Medical University, Nara, 634-8521 Japan", 
              "id": "http://www.grid.ac/institutes/grid.410814.8", 
              "name": [
                "Department of Surgery, Nara Medical University, Nara, 634-8521 Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Nagai", 
            "givenName": "Minako", 
            "id": "sg:person.01364776000.49", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01364776000.49"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Surgery, Kansai Medical University, Osaka, 573-1010 Japan", 
              "id": "http://www.grid.ac/institutes/grid.410783.9", 
              "name": [
                "Department of Surgery, Kansai Medical University, Osaka, 573-1010 Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Yanagimoto", 
            "givenName": "Hiroaki", 
            "id": "sg:person.0713716414.27", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0713716414.27"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Gastointestinal and Hepato-Biliary-Pancreatic Surgery, Faculty of Medicine, University of Tsukuba, Tsukuba, 305-8575 Japan", 
              "id": "http://www.grid.ac/institutes/grid.20515.33", 
              "name": [
                "Department of Gastointestinal and Hepato-Biliary-Pancreatic Surgery, Faculty of Medicine, University of Tsukuba, Tsukuba, 305-8575 Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Kurata", 
            "givenName": "Masanao", 
            "id": "sg:person.01343621044.70", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01343621044.70"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Surgery, Kobe University Graduate School of Medicine, Kobe, 650-0017 Japan", 
              "id": "http://www.grid.ac/institutes/grid.31432.37", 
              "name": [
                "Department of Surgery, Kobe University Graduate School of Medicine, Kobe, 650-0017 Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Fukumoto", 
            "givenName": "Takumi", 
            "id": "sg:person.01207573073.06", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01207573073.06"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Surgery, Tohoku University Graduate School of Medicine, 1-1, Seiryo-machi, Aobaku, Sendai, Miyagi 980-8574 Japan", 
              "id": "http://www.grid.ac/institutes/grid.69566.3a", 
              "name": [
                "Department of Surgery, Tohoku University Graduate School of Medicine, 1-1, Seiryo-machi, Aobaku, Sendai, Miyagi 980-8574 Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Mizuma", 
            "givenName": "Masamichi", 
            "id": "sg:person.01225732765.78", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01225732765.78"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Second Department of Surgery, Wakayama Medical University, Wakayama, 641-8510 Japan", 
              "id": "http://www.grid.ac/institutes/grid.412857.d", 
              "name": [
                "Second Department of Surgery, Wakayama Medical University, Wakayama, 641-8510 Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Yamaue", 
            "givenName": "Hiroki", 
            "id": "sg:person.01277022714.08", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01277022714.08"
            ], 
            "type": "Person"
          }, 
          {
            "affiliation": {
              "alternateName": "Department of Surgery, Tohoku University Graduate School of Medicine, 1-1, Seiryo-machi, Aobaku, Sendai, Miyagi 980-8574 Japan", 
              "id": "http://www.grid.ac/institutes/grid.69566.3a", 
              "name": [
                "Department of Surgery, Tohoku University Graduate School of Medicine, 1-1, Seiryo-machi, Aobaku, Sendai, Miyagi 980-8574 Japan"
              ], 
              "type": "Organization"
            }, 
            "familyName": "Unno", 
            "givenName": "Michiaki", 
            "id": "sg:person.01101727053.65", 
            "sameAs": [
              "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01101727053.65"
            ], 
            "type": "Person"
          }, 
          {}
        ], 
        "citation": [
          {
            "id": "sg:pub.10.1245/s10434-011-2020-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1047387158", 
              "https://doi.org/10.1245/s10434-011-2020-9"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1245/s10434-011-2049-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1010098383", 
              "https://doi.org/10.1245/s10434-011-2049-9"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s002689900215", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1050456898", 
              "https://doi.org/10.1007/s002689900215"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1038/sj.bjc.6605256", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1043189393", 
              "https://doi.org/10.1038/sj.bjc.6605256"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1245/s10434-007-9384-x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1041390111", 
              "https://doi.org/10.1245/s10434-007-9384-x"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00534-013-0616-0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1025006134", 
              "https://doi.org/10.1007/s00534-013-0616-0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s11605-012-1859-9", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1005915739", 
              "https://doi.org/10.1007/s11605-012-1859-9"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1245/s10434-010-1311-x", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1038641408", 
              "https://doi.org/10.1245/s10434-010-1311-x"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s11605-009-0919-2", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1052526509", 
              "https://doi.org/10.1007/s11605-009-0919-2"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1245/s10434-010-1033-0", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1001836237", 
              "https://doi.org/10.1245/s10434-010-1033-0"
            ], 
            "type": "CreativeWork"
          }, 
          {
            "id": "sg:pub.10.1007/s00534-011-0391-8", 
            "sameAs": [
              "https://app.dimensions.ai/details/publication/pub.1027380427", 
              "https://doi.org/10.1007/s00534-011-0391-8"
            ], 
            "type": "CreativeWork"
          }
        ], 
        "datePublished": "2019-03-21", 
        "datePublishedReg": "2019-03-21", 
        "description": "BACKGROUND: Carbohydrate antigen (CA) 19-9 levels after resection are considered to predict prognosis; however, the significance of decreased CA19-9 levels after neoadjuvant therapy has not been clarified. This study aimed to define the prognostic significance of decreased CA19-9 levels after neoadjuvant therapy in patients with pancreatic adenocarcinoma.\nMETHODS: Between 2001 and 2012, 240 consecutive patients received neoadjuvant therapy and subsequent resection at seven high-volume institutions in Japan. These patients were divided into three groups: Normal group (no elevation [\u226437\u2009U/ml] before and after neoadjuvant therapy), Responder group (elevated levels [>\u200937\u2009U/ml] before neoadjuvant therapy but decreased levels [\u226437\u2009U/ml] afterwards), and Non-responder group (elevated levels [>\u200937\u2009U/ml] after neoadjuvant therapy). Analyses of overall survival and recurrence patterns were performed. Uni- and multivariate analyses were performed to clarify the clinicopathological factors influencing overall survival. The initial metastasis sites were also evaluated in these groups.\nRESULTS: The Responder group received a better prognosis than the Non-responder group (3-year overall survival: 50.6 and 41.6%, respectively, P\u2009=\u20090.026), but the prognosis was comparable to the Normal group (3-year overall survival: 54.2%, P\u2009=\u20090.934). According to the analysis of the receiver operating characteristic curve, the CA19-9 cut-off level defined as no elevation after neoadjuvant therapy was \u2264103\u2009U/ml. The multivariate analysis revealed that a CA19-9 level\u2009\u2264\u2009103\u2009U/ml, (P\u2009=\u20090.010, hazard ratio: 1.711; 95% confidence interval: 1.133-2.639), tumor size \u226427\u2009mm (P\u2009=\u20090.040, 1.517; (1.018-2.278)), a lack of lymph node metastasis (P\u2009=\u20090.002, 1.905; (1.276-2.875)), and R0 status (P\u2009=\u20090.045, 1.659; 1.012-2.627) were significant predictors of overall survival. Moreover, the Responder group showed a lower risk of hepatic recurrence (18%) compared to the Non-responder group (31%), though no significant difference in loco-regional, peritoneal or other distant recurrence were observed between groups (P\u2009=\u20090.058, P\u2009=\u20090.700 and P\u2009=\u20090.350, respectively).\nCONCLUSIONS: Decreased CA19-9 levels after neoadjuvant therapy predicts a better prognosis, with low incidence of hepatic recurrence after surgery.", 
        "genre": "article", 
        "id": "sg:pub.10.1186/s12885-019-5460-4", 
        "inLanguage": "en", 
        "isAccessibleForFree": true, 
        "isFundedItemOf": [
          {
            "id": "sg:grant.9338766", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.5923042", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.6819799", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.5920518", 
            "type": "MonetaryGrant"
          }, 
          {
            "id": "sg:grant.9339689", 
            "type": "MonetaryGrant"
          }
        ], 
        "isPartOf": [
          {
            "id": "sg:journal.1024632", 
            "issn": [
              "1471-2407"
            ], 
            "name": "BMC Cancer", 
            "publisher": "Springer Nature", 
            "type": "Periodical"
          }, 
          {
            "issueNumber": "1", 
            "type": "PublicationIssue"
          }, 
          {
            "type": "PublicationVolume", 
            "volumeNumber": "19"
          }
        ], 
        "keywords": [
          "CA19-9 levels", 
          "non-responder group", 
          "neoadjuvant therapy", 
          "carbohydrate antigen 19", 
          "overall survival", 
          "better prognosis", 
          "responder group", 
          "hepatic recurrence", 
          "antigen 19", 
          "pancreatic adenocarcinoma", 
          "normal group", 
          "multivariate analysis", 
          "serum carbohydrate antigen 19", 
          "multicenter case-control study", 
          "lymph node metastasis", 
          "high-volume institutions", 
          "case-control study", 
          "CA19-9 cut", 
          "distant recurrence", 
          "consecutive patients", 
          "subsequent resection", 
          "R0 status", 
          "clinicopathological factors", 
          "node metastasis", 
          "prognostic significance", 
          "tumor size", 
          "metastasis sites", 
          "recurrence patterns", 
          "lower incidence", 
          "lower risk", 
          "prognosis", 
          "patients", 
          "therapy", 
          "recurrence", 
          "significant predictors", 
          "resection", 
          "characteristic curve", 
          "significant differences", 
          "adenocarcinoma", 
          "survival", 
          "group", 
          "levels", 
          "surgery", 
          "metastasis", 
          "incidence", 
          "risk", 
          "significance", 
          "predictors", 
          "study", 
          "elevation", 
          "Uni", 
          "status", 
          "factors", 
          "analysis", 
          "differences", 
          "lack", 
          "patterns", 
          "institutions", 
          "sites", 
          "curves", 
          "Japan", 
          "receiver", 
          "cut", 
          "size", 
          "initial metastasis sites"
        ], 
        "name": "Decreased serum carbohydrate antigen 19\u20139 levels after neoadjuvant therapy predict a better prognosis for patients with pancreatic adenocarcinoma: a multicenter case-control study of 240 patients", 
        "pagination": "252", 
        "productId": [
          {
            "name": "dimensions_id", 
            "type": "PropertyValue", 
            "value": [
              "pub.1112926598"
            ]
          }, 
          {
            "name": "doi", 
            "type": "PropertyValue", 
            "value": [
              "10.1186/s12885-019-5460-4"
            ]
          }, 
          {
            "name": "pubmed_id", 
            "type": "PropertyValue", 
            "value": [
              "30898101"
            ]
          }
        ], 
        "sameAs": [
          "https://doi.org/10.1186/s12885-019-5460-4", 
          "https://app.dimensions.ai/details/publication/pub.1112926598"
        ], 
        "sdDataset": "articles", 
        "sdDatePublished": "2021-12-01T19:46", 
        "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
        "sdPublisher": {
          "name": "Springer Nature - SN SciGraph project", 
          "type": "Organization"
        }, 
        "sdSource": "s3://com-springernature-scigraph/baseset/20211201/entities/gbq_results/article/article_832.jsonl", 
        "type": "ScholarlyArticle", 
        "url": "https://doi.org/10.1186/s12885-019-5460-4"
      }
    ]
     

    Download the RDF metadata as:  json-ld nt turtle xml License info

    HOW TO GET THIS DATA PROGRAMMATICALLY:

    JSON-LD is a popular format for linked data which is fully compatible with JSON.

    curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/s12885-019-5460-4'

    N-Triples is a line-based linked data format ideal for batch operations.

    curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/s12885-019-5460-4'

    Turtle is a human-readable linked data format.

    curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/s12885-019-5460-4'

    RDF/XML is a standard XML format for linked data.

    curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/s12885-019-5460-4'


     

    This table displays all metadata directly associated to this object as RDF triples.

    391 TRIPLES      22 PREDICATES      122 URIs      103 LITERALS      27 BLANK NODES

    Subject Predicate Object
    1 sg:pub.10.1186/s12885-019-5460-4 schema:about N07de62359a964c9ea6f21702240fc8b4
    2 N111d438c333544f3ac76e840dc46a476
    3 N1de149ac689545b1abde6073629a63a3
    4 N203866425064421aa06a5a41c0826a1e
    5 N2d7ff1fc493b431da2ffff675ef01aa8
    6 N367d003c894244e88400528d0a31160f
    7 N428a2c5af728400597e8a44b19a6ee01
    8 N46227bff72114ab3b1405ff687ebb218
    9 N49010773d25240f0ba13d81a0ddae37e
    10 N6b8420763cb8410cb7c3357b50e890de
    11 N9c32dfb321034bb1b199df951b20c800
    12 N9e768974eb914b109ab3d460e5275598
    13 Na9e5efc55d994fcf9698aad924049e77
    14 Nb09b09ceb14d4d3b84b9406ee03ce3ee
    15 Nbe5e8a934b5147de8ed6e782c30a78c6
    16 Nc107b870438847fc9f1d4d00c1fde461
    17 Nc4b69f6598cb45cd926fe8f98fce4ecf
    18 Nc76e87fce8c64c8e919ef97f724e990e
    19 Nd6d8fe571a1e48fda2e95ee4770dcea3
    20 Neafb3d81b0264e9186b823e0961b8ce8
    21 anzsrc-for:11
    22 anzsrc-for:1112
    23 schema:author N08ba53774d6145649637be45a20a5382
    24 schema:citation sg:pub.10.1007/s002689900215
    25 sg:pub.10.1007/s00534-011-0391-8
    26 sg:pub.10.1007/s00534-013-0616-0
    27 sg:pub.10.1007/s11605-009-0919-2
    28 sg:pub.10.1007/s11605-012-1859-9
    29 sg:pub.10.1038/sj.bjc.6605256
    30 sg:pub.10.1245/s10434-007-9384-x
    31 sg:pub.10.1245/s10434-010-1033-0
    32 sg:pub.10.1245/s10434-010-1311-x
    33 sg:pub.10.1245/s10434-011-2020-9
    34 sg:pub.10.1245/s10434-011-2049-9
    35 schema:datePublished 2019-03-21
    36 schema:datePublishedReg 2019-03-21
    37 schema:description BACKGROUND: Carbohydrate antigen (CA) 19-9 levels after resection are considered to predict prognosis; however, the significance of decreased CA19-9 levels after neoadjuvant therapy has not been clarified. This study aimed to define the prognostic significance of decreased CA19-9 levels after neoadjuvant therapy in patients with pancreatic adenocarcinoma. METHODS: Between 2001 and 2012, 240 consecutive patients received neoadjuvant therapy and subsequent resection at seven high-volume institutions in Japan. These patients were divided into three groups: Normal group (no elevation [≤37 U/ml] before and after neoadjuvant therapy), Responder group (elevated levels [> 37 U/ml] before neoadjuvant therapy but decreased levels [≤37 U/ml] afterwards), and Non-responder group (elevated levels [> 37 U/ml] after neoadjuvant therapy). Analyses of overall survival and recurrence patterns were performed. Uni- and multivariate analyses were performed to clarify the clinicopathological factors influencing overall survival. The initial metastasis sites were also evaluated in these groups. RESULTS: The Responder group received a better prognosis than the Non-responder group (3-year overall survival: 50.6 and 41.6%, respectively, P = 0.026), but the prognosis was comparable to the Normal group (3-year overall survival: 54.2%, P = 0.934). According to the analysis of the receiver operating characteristic curve, the CA19-9 cut-off level defined as no elevation after neoadjuvant therapy was ≤103 U/ml. The multivariate analysis revealed that a CA19-9 level ≤ 103 U/ml, (P = 0.010, hazard ratio: 1.711; 95% confidence interval: 1.133-2.639), tumor size ≤27 mm (P = 0.040, 1.517; (1.018-2.278)), a lack of lymph node metastasis (P = 0.002, 1.905; (1.276-2.875)), and R0 status (P = 0.045, 1.659; 1.012-2.627) were significant predictors of overall survival. Moreover, the Responder group showed a lower risk of hepatic recurrence (18%) compared to the Non-responder group (31%), though no significant difference in loco-regional, peritoneal or other distant recurrence were observed between groups (P = 0.058, P = 0.700 and P = 0.350, respectively). CONCLUSIONS: Decreased CA19-9 levels after neoadjuvant therapy predicts a better prognosis, with low incidence of hepatic recurrence after surgery.
    38 schema:genre article
    39 schema:inLanguage en
    40 schema:isAccessibleForFree true
    41 schema:isPartOf N25d90557413443c68cc0d04f51fadc27
    42 Nd6b0caab421047dfa70692803eb6b2d6
    43 sg:journal.1024632
    44 schema:keywords CA19-9 cut
    45 CA19-9 levels
    46 Japan
    47 R0 status
    48 Uni
    49 adenocarcinoma
    50 analysis
    51 antigen 19
    52 better prognosis
    53 carbohydrate antigen 19
    54 case-control study
    55 characteristic curve
    56 clinicopathological factors
    57 consecutive patients
    58 curves
    59 cut
    60 differences
    61 distant recurrence
    62 elevation
    63 factors
    64 group
    65 hepatic recurrence
    66 high-volume institutions
    67 incidence
    68 initial metastasis sites
    69 institutions
    70 lack
    71 levels
    72 lower incidence
    73 lower risk
    74 lymph node metastasis
    75 metastasis
    76 metastasis sites
    77 multicenter case-control study
    78 multivariate analysis
    79 neoadjuvant therapy
    80 node metastasis
    81 non-responder group
    82 normal group
    83 overall survival
    84 pancreatic adenocarcinoma
    85 patients
    86 patterns
    87 predictors
    88 prognosis
    89 prognostic significance
    90 receiver
    91 recurrence
    92 recurrence patterns
    93 resection
    94 responder group
    95 risk
    96 serum carbohydrate antigen 19
    97 significance
    98 significant differences
    99 significant predictors
    100 sites
    101 size
    102 status
    103 study
    104 subsequent resection
    105 surgery
    106 survival
    107 therapy
    108 tumor size
    109 schema:name Decreased serum carbohydrate antigen 19–9 levels after neoadjuvant therapy predict a better prognosis for patients with pancreatic adenocarcinoma: a multicenter case-control study of 240 patients
    110 schema:pagination 252
    111 schema:productId Naacee7c711f24b4684113428774573ee
    112 Ncf26a6947c8b4287a7030835b6ddf071
    113 Nd0416aa7ed254a348fc285d4565ec628
    114 schema:sameAs https://app.dimensions.ai/details/publication/pub.1112926598
    115 https://doi.org/10.1186/s12885-019-5460-4
    116 schema:sdDatePublished 2021-12-01T19:46
    117 schema:sdLicense https://scigraph.springernature.com/explorer/license/
    118 schema:sdPublisher Nefd2762bf11d452f83abd602937f1811
    119 schema:url https://doi.org/10.1186/s12885-019-5460-4
    120 sgo:license sg:explorer/license/
    121 sgo:sdDataset articles
    122 rdf:type schema:ScholarlyArticle
    123 N07de62359a964c9ea6f21702240fc8b4 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    124 schema:name Carcinoma, Pancreatic Ductal
    125 rdf:type schema:DefinedTerm
    126 N08ba53774d6145649637be45a20a5382 rdf:first sg:person.0623100010.00
    127 rdf:rest N8bf84fea92764db7b88347a7a9464cc6
    128 N111d438c333544f3ac76e840dc46a476 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    129 schema:name Middle Aged
    130 rdf:type schema:DefinedTerm
    131 N1de149ac689545b1abde6073629a63a3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    132 schema:name Aged, 80 and over
    133 rdf:type schema:DefinedTerm
    134 N1eaf00b773664714a627738637859007 rdf:first sg:person.01277022714.08
    135 rdf:rest N89a9c5848c8a4accbaad5c06508d8a75
    136 N203866425064421aa06a5a41c0826a1e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    137 schema:name Aged
    138 rdf:type schema:DefinedTerm
    139 N25d90557413443c68cc0d04f51fadc27 schema:volumeNumber 19
    140 rdf:type schema:PublicationVolume
    141 N2d7ff1fc493b431da2ffff675ef01aa8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    142 schema:name Adult
    143 rdf:type schema:DefinedTerm
    144 N36144f8403f54888951a9df3332aa57d rdf:first sg:person.01151604541.22
    145 rdf:rest N7c59bda7b9f345eebf02c5191889c461
    146 N367d003c894244e88400528d0a31160f schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    147 schema:name Male
    148 rdf:type schema:DefinedTerm
    149 N428a2c5af728400597e8a44b19a6ee01 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    150 schema:name Humans
    151 rdf:type schema:DefinedTerm
    152 N46227bff72114ab3b1405ff687ebb218 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    153 schema:name Neoplasm Recurrence, Local
    154 rdf:type schema:DefinedTerm
    155 N49010773d25240f0ba13d81a0ddae37e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    156 schema:name Antineoplastic Combined Chemotherapy Protocols
    157 rdf:type schema:DefinedTerm
    158 N56de55547fe84f34a5410f7dda33519d rdf:first sg:person.0705470262.13
    159 rdf:rest Nf721aab360014efdaabad4f6bd02dc36
    160 N57abaf00a8df4068829ab9b714d0431d rdf:first sg:person.01225732765.78
    161 rdf:rest N1eaf00b773664714a627738637859007
    162 N682b163b7c07490684039229d14cbe77 rdf:first sg:person.0740320344.58
    163 rdf:rest N56de55547fe84f34a5410f7dda33519d
    164 N6b8420763cb8410cb7c3357b50e890de schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    165 schema:name Neoadjuvant Therapy
    166 rdf:type schema:DefinedTerm
    167 N7c59bda7b9f345eebf02c5191889c461 rdf:first sg:person.01270724636.90
    168 rdf:rest Nd6e0b43ee733422dbcd81be48ad326bb
    169 N7f8d3d19d0c84deea0df64331b64f28f rdf:first N4da599f85be8434e921b19857b3dfc51
    170 rdf:rest rdf:nil
    171 N89a9c5848c8a4accbaad5c06508d8a75 rdf:first sg:person.01101727053.65
    172 rdf:rest N7f8d3d19d0c84deea0df64331b64f28f
    173 N8bf84fea92764db7b88347a7a9464cc6 rdf:first sg:person.01260427553.25
    174 rdf:rest N682b163b7c07490684039229d14cbe77
    175 N9c32dfb321034bb1b199df951b20c800 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    176 schema:name CA-19-9 Antigen
    177 rdf:type schema:DefinedTerm
    178 N9d10f484a74542e8979b64a2180e2bb2 rdf:first sg:person.01207573073.06
    179 rdf:rest N57abaf00a8df4068829ab9b714d0431d
    180 N9e768974eb914b109ab3d460e5275598 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    181 schema:name Survival Analysis
    182 rdf:type schema:DefinedTerm
    183 N9f2ad7c150364ed9b760abab40bd9de4 rdf:first sg:person.0713716414.27
    184 rdf:rest Nea5fb250d26240c7ae15a27b045c7286
    185 Na9e5efc55d994fcf9698aad924049e77 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    186 schema:name Liver Neoplasms
    187 rdf:type schema:DefinedTerm
    188 Naacee7c711f24b4684113428774573ee schema:name pubmed_id
    189 schema:value 30898101
    190 rdf:type schema:PropertyValue
    191 Nb09b09ceb14d4d3b84b9406ee03ce3ee schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    192 schema:name Response Evaluation Criteria in Solid Tumors
    193 rdf:type schema:DefinedTerm
    194 Nbe5e8a934b5147de8ed6e782c30a78c6 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    195 schema:name Case-Control Studies
    196 rdf:type schema:DefinedTerm
    197 Nc107b870438847fc9f1d4d00c1fde461 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    198 schema:name Prognosis
    199 rdf:type schema:DefinedTerm
    200 Nc4b69f6598cb45cd926fe8f98fce4ecf schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    201 schema:name Female
    202 rdf:type schema:DefinedTerm
    203 Nc76e87fce8c64c8e919ef97f724e990e schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    204 schema:name Incidence
    205 rdf:type schema:DefinedTerm
    206 Nce93b2d1bf4d447e8e9af2401c1ab1ec rdf:first sg:person.01342345220.29
    207 rdf:rest N36144f8403f54888951a9df3332aa57d
    208 Ncf26a6947c8b4287a7030835b6ddf071 schema:name dimensions_id
    209 schema:value pub.1112926598
    210 rdf:type schema:PropertyValue
    211 Nd0416aa7ed254a348fc285d4565ec628 schema:name doi
    212 schema:value 10.1186/s12885-019-5460-4
    213 rdf:type schema:PropertyValue
    214 Nd6b0caab421047dfa70692803eb6b2d6 schema:issueNumber 1
    215 rdf:type schema:PublicationIssue
    216 Nd6d8fe571a1e48fda2e95ee4770dcea3 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    217 schema:name Pancreatic Neoplasms
    218 rdf:type schema:DefinedTerm
    219 Nd6e0b43ee733422dbcd81be48ad326bb rdf:first sg:person.01142257124.18
    220 rdf:rest Nf1b1956972d34d7fbddff0829eca1028
    221 Nea5fb250d26240c7ae15a27b045c7286 rdf:first sg:person.01343621044.70
    222 rdf:rest N9d10f484a74542e8979b64a2180e2bb2
    223 Neafb3d81b0264e9186b823e0961b8ce8 schema:inDefinedTermSet https://www.nlm.nih.gov/mesh/
    224 schema:name Pancreatectomy
    225 rdf:type schema:DefinedTerm
    226 Nefd2762bf11d452f83abd602937f1811 schema:name Springer Nature - SN SciGraph project
    227 rdf:type schema:Organization
    228 Nf1b1956972d34d7fbddff0829eca1028 rdf:first sg:person.01364776000.49
    229 rdf:rest N9f2ad7c150364ed9b760abab40bd9de4
    230 Nf721aab360014efdaabad4f6bd02dc36 rdf:first sg:person.01122437244.79
    231 rdf:rest Nce93b2d1bf4d447e8e9af2401c1ab1ec
    232 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
    233 schema:name Medical and Health Sciences
    234 rdf:type schema:DefinedTerm
    235 anzsrc-for:1112 schema:inDefinedTermSet anzsrc-for:
    236 schema:name Oncology and Carcinogenesis
    237 rdf:type schema:DefinedTerm
    238 sg:grant.5920518 http://pending.schema.org/fundedItem sg:pub.10.1186/s12885-019-5460-4
    239 rdf:type schema:MonetaryGrant
    240 sg:grant.5923042 http://pending.schema.org/fundedItem sg:pub.10.1186/s12885-019-5460-4
    241 rdf:type schema:MonetaryGrant
    242 sg:grant.6819799 http://pending.schema.org/fundedItem sg:pub.10.1186/s12885-019-5460-4
    243 rdf:type schema:MonetaryGrant
    244 sg:grant.9338766 http://pending.schema.org/fundedItem sg:pub.10.1186/s12885-019-5460-4
    245 rdf:type schema:MonetaryGrant
    246 sg:grant.9339689 http://pending.schema.org/fundedItem sg:pub.10.1186/s12885-019-5460-4
    247 rdf:type schema:MonetaryGrant
    248 sg:journal.1024632 schema:issn 1471-2407
    249 schema:name BMC Cancer
    250 schema:publisher Springer Nature
    251 rdf:type schema:Periodical
    252 sg:person.01101727053.65 schema:affiliation grid-institutes:grid.69566.3a
    253 schema:familyName Unno
    254 schema:givenName Michiaki
    255 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01101727053.65
    256 rdf:type schema:Person
    257 sg:person.01122437244.79 schema:affiliation grid-institutes:grid.410783.9
    258 schema:familyName Satoi
    259 schema:givenName Sohei
    260 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01122437244.79
    261 rdf:type schema:Person
    262 sg:person.01142257124.18 schema:affiliation grid-institutes:grid.258622.9
    263 schema:familyName Matsumoto
    264 schema:givenName Ippei
    265 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01142257124.18
    266 rdf:type schema:Person
    267 sg:person.01151604541.22 schema:affiliation grid-institutes:grid.257022.0
    268 schema:familyName Uemura
    269 schema:givenName Kenichiro
    270 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01151604541.22
    271 rdf:type schema:Person
    272 sg:person.01207573073.06 schema:affiliation grid-institutes:grid.31432.37
    273 schema:familyName Fukumoto
    274 schema:givenName Takumi
    275 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01207573073.06
    276 rdf:type schema:Person
    277 sg:person.01225732765.78 schema:affiliation grid-institutes:grid.69566.3a
    278 schema:familyName Mizuma
    279 schema:givenName Masamichi
    280 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01225732765.78
    281 rdf:type schema:Person
    282 sg:person.01260427553.25 schema:affiliation grid-institutes:grid.69566.3a
    283 schema:familyName Motoi
    284 schema:givenName Fuyuhiko
    285 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01260427553.25
    286 rdf:type schema:Person
    287 sg:person.01270724636.90 schema:affiliation grid-institutes:grid.412857.d
    288 schema:familyName Okada
    289 schema:givenName Ken-ichi
    290 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01270724636.90
    291 rdf:type schema:Person
    292 sg:person.01277022714.08 schema:affiliation grid-institutes:grid.412857.d
    293 schema:familyName Yamaue
    294 schema:givenName Hiroki
    295 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01277022714.08
    296 rdf:type schema:Person
    297 sg:person.01342345220.29 schema:affiliation grid-institutes:grid.415479.a
    298 schema:familyName Honda
    299 schema:givenName Goro
    300 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01342345220.29
    301 rdf:type schema:Person
    302 sg:person.01343621044.70 schema:affiliation grid-institutes:grid.20515.33
    303 schema:familyName Kurata
    304 schema:givenName Masanao
    305 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01343621044.70
    306 rdf:type schema:Person
    307 sg:person.01364776000.49 schema:affiliation grid-institutes:grid.410814.8
    308 schema:familyName Nagai
    309 schema:givenName Minako
    310 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01364776000.49
    311 rdf:type schema:Person
    312 sg:person.0623100010.00 schema:affiliation grid-institutes:grid.69566.3a
    313 schema:familyName Aoki
    314 schema:givenName Shuichi
    315 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0623100010.00
    316 rdf:type schema:Person
    317 sg:person.0705470262.13 schema:affiliation grid-institutes:grid.410814.8
    318 schema:familyName Sho
    319 schema:givenName Masayuki
    320 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0705470262.13
    321 rdf:type schema:Person
    322 sg:person.0713716414.27 schema:affiliation grid-institutes:grid.410783.9
    323 schema:familyName Yanagimoto
    324 schema:givenName Hiroaki
    325 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0713716414.27
    326 rdf:type schema:Person
    327 sg:person.0740320344.58 schema:affiliation grid-institutes:grid.257022.0
    328 schema:familyName Murakami
    329 schema:givenName Yoshiaki
    330 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0740320344.58
    331 rdf:type schema:Person
    332 sg:pub.10.1007/s002689900215 schema:sameAs https://app.dimensions.ai/details/publication/pub.1050456898
    333 https://doi.org/10.1007/s002689900215
    334 rdf:type schema:CreativeWork
    335 sg:pub.10.1007/s00534-011-0391-8 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027380427
    336 https://doi.org/10.1007/s00534-011-0391-8
    337 rdf:type schema:CreativeWork
    338 sg:pub.10.1007/s00534-013-0616-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1025006134
    339 https://doi.org/10.1007/s00534-013-0616-0
    340 rdf:type schema:CreativeWork
    341 sg:pub.10.1007/s11605-009-0919-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1052526509
    342 https://doi.org/10.1007/s11605-009-0919-2
    343 rdf:type schema:CreativeWork
    344 sg:pub.10.1007/s11605-012-1859-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1005915739
    345 https://doi.org/10.1007/s11605-012-1859-9
    346 rdf:type schema:CreativeWork
    347 sg:pub.10.1038/sj.bjc.6605256 schema:sameAs https://app.dimensions.ai/details/publication/pub.1043189393
    348 https://doi.org/10.1038/sj.bjc.6605256
    349 rdf:type schema:CreativeWork
    350 sg:pub.10.1245/s10434-007-9384-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1041390111
    351 https://doi.org/10.1245/s10434-007-9384-x
    352 rdf:type schema:CreativeWork
    353 sg:pub.10.1245/s10434-010-1033-0 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001836237
    354 https://doi.org/10.1245/s10434-010-1033-0
    355 rdf:type schema:CreativeWork
    356 sg:pub.10.1245/s10434-010-1311-x schema:sameAs https://app.dimensions.ai/details/publication/pub.1038641408
    357 https://doi.org/10.1245/s10434-010-1311-x
    358 rdf:type schema:CreativeWork
    359 sg:pub.10.1245/s10434-011-2020-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1047387158
    360 https://doi.org/10.1245/s10434-011-2020-9
    361 rdf:type schema:CreativeWork
    362 sg:pub.10.1245/s10434-011-2049-9 schema:sameAs https://app.dimensions.ai/details/publication/pub.1010098383
    363 https://doi.org/10.1245/s10434-011-2049-9
    364 rdf:type schema:CreativeWork
    365 grid-institutes:grid.20515.33 schema:alternateName Department of Gastointestinal and Hepato-Biliary-Pancreatic Surgery, Faculty of Medicine, University of Tsukuba, Tsukuba, 305-8575 Japan
    366 schema:name Department of Gastointestinal and Hepato-Biliary-Pancreatic Surgery, Faculty of Medicine, University of Tsukuba, Tsukuba, 305-8575 Japan
    367 rdf:type schema:Organization
    368 grid-institutes:grid.257022.0 schema:alternateName Department of Surgery, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, 734-8553 Japan
    369 schema:name Department of Surgery, Institute of Biomedical and Health Sciences, Hiroshima University, Hiroshima, 734-8553 Japan
    370 rdf:type schema:Organization
    371 grid-institutes:grid.258622.9 schema:alternateName Department of Surgery, Kindai University Faculty of Medicine, Osaka, 577-8502 Japan
    372 schema:name Department of Surgery, Kindai University Faculty of Medicine, Osaka, 577-8502 Japan
    373 rdf:type schema:Organization
    374 grid-institutes:grid.31432.37 schema:alternateName Department of Surgery, Kobe University Graduate School of Medicine, Kobe, 650-0017 Japan
    375 schema:name Department of Surgery, Kobe University Graduate School of Medicine, Kobe, 650-0017 Japan
    376 rdf:type schema:Organization
    377 grid-institutes:grid.410783.9 schema:alternateName Department of Surgery, Kansai Medical University, Osaka, 573-1010 Japan
    378 schema:name Department of Surgery, Kansai Medical University, Osaka, 573-1010 Japan
    379 rdf:type schema:Organization
    380 grid-institutes:grid.410814.8 schema:alternateName Department of Surgery, Nara Medical University, Nara, 634-8521 Japan
    381 schema:name Department of Surgery, Nara Medical University, Nara, 634-8521 Japan
    382 rdf:type schema:Organization
    383 grid-institutes:grid.412857.d schema:alternateName Second Department of Surgery, Wakayama Medical University, Wakayama, 641-8510 Japan
    384 schema:name Second Department of Surgery, Wakayama Medical University, Wakayama, 641-8510 Japan
    385 rdf:type schema:Organization
    386 grid-institutes:grid.415479.a schema:alternateName Department of Surgery, Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital, Tokyo, 113-8677 Japan
    387 schema:name Department of Surgery, Tokyo Metropolitan Cancer and Infectious diseases Center Komagome Hospital, Tokyo, 113-8677 Japan
    388 rdf:type schema:Organization
    389 grid-institutes:grid.69566.3a schema:alternateName Department of Surgery, Tohoku University Graduate School of Medicine, 1-1, Seiryo-machi, Aobaku, Sendai, Miyagi 980-8574 Japan
    390 schema:name Department of Surgery, Tohoku University Graduate School of Medicine, 1-1, Seiryo-machi, Aobaku, Sendai, Miyagi 980-8574 Japan
    391 rdf:type schema:Organization
     




    Preview window. Press ESC to close (or click here)


    ...